Ioannis Xinias

Prof. Ioannis Xinias

orcid

Research Focus & Metrics

Academic Career Length

18Years (2009-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
20 March 2013 in Case Reports in Gastroenterology
Verified
Journal Article
Open access
PDF file
IXIoannis Xinias
Ioannis Xinias
AMAntigoni Mavroudi
Antigoni Mavroudi
ESEvi Sapountzi
Evi Sapountzi
ATAgathi Thomaidou
Agathi Thomaidou
MFMaria Fotoulaki
Maria Fotoulaki
GIGeorge Imvrios
George Imvrios
Primary intestinal lymphangiectasia (PIL) or Waldmann's disease is a rare protein-losing gastroenteropathy of unknown etiology. Less than 200 cases have been reported globally. Patients may be asymptomatic or present edema, lymphedema, diarrhea, ascites and other manifestations. We report two pediatric cases with PIL with extremely different outcome in a 3-year follow-up period. The first patient presented with persistent diarrhea, hypoalbuminemia and failure to thrive, while the second patient presented with an abrupt eyelid edema. Hypoproteinemia was the common laboratory finding for the two patients and upper gastrointestinal endoscopy established the diagnosis. The first patient relapsed five times during the follow-up period after the diagnosis had been made and required intravenous albumin administration and micronutrient supplementation. The second patient revealed normal gastrointestinal endoscopy 4 months after the diagnosis had been established; he followed an unrestricted diet and remained asymptomatic throughout the follow-up period. PIL can be either severe, affecting the entire small bowel, leading to lifetime disease, or sometimes affects part of the small bowel, leading to transient disorder.

1 January 2012 in Case Reports in Gastroenterology
Verified
Journal Article
Open access
PDF file
IXIoannis Xinias
Ioannis Xinias
AMA. Mavroudi
A. Mavroudi
MFM. Fotoulaki
M. Fotoulaki
GTG. Tsikopoulos
G. Tsikopoulos
AKA. Kalampakas
A. Kalampakas
GIG. Imvrios
G. Imvrios
Meckel’s diverticulum (MD) is the most common congenital anomaly of the gastrointestinal (GI) tract, affecting about 2% of the population. Most cases of Meckel’s diverticula are asymptomatic. The diagnosis of symptomatic MD is often difficult to make. We report the case of an 8-year-old boy who presented with GI bleeding due to MD. The diagnostic difficulties after an initial negative endoscopic evaluation and the diagnostic value of the various endoscopic procedures are discussed. The patient had suffered from bright red stools for 20 h before hospital admission. GI scintigraphy with 99mTc-Na-pertechnetate was negative for heterotopic gastric tissue in the small bowel area. Colonoscopy performed in order to exclude Crohn’s disease was also negative. He was placed on ranitidine at a dose of 6 mg/kg body weight twice daily. The patient remained asymptomatic over a period of 6 months before he was readmitted due to macroscopic rectal bleeding. Upper endoscopy and colonoscopy used to investigate the source of bleeding showed normal macroscopic findings. Radiolabeling of blood constituents with 99mTc on delayed imaging showed radionucleotide concentration in the ascending and transverse colon suggestive of a lesion in the ileocecal area. Further investigation with the use of wireless capsule endoscopy revealed a MD. Wireless capsule endoscopy may thus be indicated for patients with GI blood loss when other diagnostic methods, such as upper and lower endoscopy and colonoscopy, have failed to identify the source of bleeding.

27 January 2009 in World Journal of Pediatrics
Verified
Journal Article
Closed access
PDF file
IXIoannis Xinias
Ioannis Xinias
VDVasiliki Demertzidou
Vasiliki Demertzidou
AMAntigoni Mavroudi
Antigoni Mavroudi
KKKonstantinos Kollios
Konstantinos Kollios
PKPanagiotis Kardaras
Panagiotis Kardaras
ITIoannis Tsiouris
Ioannis Tsiouris

6 October 2015
Verified
Journal Article
Closed access
IXIoannis Xinias
Ioannis Xinias
AMA Mavroudi
A Mavroudi

9 August 2024 in Nutrients
Verified
Journal Article
Open access
PDF file
Charikleia STEFANAKICharikleia STEFANAKI
Charikleia STEFANAKI
PRParaskevi Rozou
Paraskevi Rozou
VEVasiliki Efthymiou
Vasiliki Efthymiou
IXIoannis Xinias
Ioannis Xinias
George MastorakosGeorge Mastorakos
George Mastorakos
Papagianni MariaPapagianni Maria
Papagianni Maria
Aims: Human recombinant insulin is currently the only therapy for children and adolescents with type 1 diabetes (T1D), although not always efficient for the glycemic control of these individuals. The interrelation between the gut microbiome and the glycemic control of apparently healthy populations, as well as various populations with diabetes, is undeniable. Probiotics are biotherapeutics that deliver active components to various targets, primarily the gastrointestinal tract. This systematic review and meta-analysis examined the effect of the administration of probiotics on the glycemic control of pediatric and adolescent individuals with T1D. Materials and Methods: Randomized controlled trials employing the administration of probiotics in children and adolescents with T1D (with ≥10 individuals per treatment arm), written in English, providing parameters of glycemic control, such as mean glucose concentrations and glycosylated hemoglobin (HbA1c), were deemed eligible. Results: The search strategy resulted in six papers with contradictory findings. Ultimately, five studies of acceptable quality, comprising 388 children and adolescents with T1D, were included in the meta-analysis. Employing a random and fixed effects model revealed statistically significant negative effect sizes of probiotics on the glycemic control of those individuals, i.e., higher concentrations of glucose and HbA1c than controls. Conclusions: Children and adolescents with T1D who received probiotics demonstrated worse glycemic control than controls after the intervention. Adequately powered studies, with extended follow-up periods, along with monitoring of compliance and employing the proper strains, are required to unravel the mechanisms of action and the relative effects of probiotics, particularly concerning diabetes-related complications and metabolic outcomes.

26 February 2013 in Pediatric Reports
Verified
Journal Article
Open access
PDF file
IXIoannis Xinias
Ioannis Xinias
TMTheophanis Maris
Theophanis Maris
AMAntigoni Mavroudi
Antigoni Mavroudi
CPChristos Panteliadis
Christos Panteliadis
Yvan VandenplasYvan Vandenplas
Yvan Vandenplas
The relationship between Helicobacter pylori (Hp) gastritis and gastroesophageal reflux disease (GERD) remains controversial. The aim was to investigate the association between Hp infection and gastroesophageal reflux (GER) and the impact of Hp eradication on esophageal acid exposure and motility in adolescents and young adults with Hp gastritis and GERD. Sixty-four patients with symptoms suggestive for GERD, of which 40 Hp-positive (group A) and 24 Hp-negative (group B), underwent endoscopy-biopsy, esophageal manometry and 24-hour pH-metry. All group A patients received eradication treatment and were re-evaluated six months later again with 24-hour pH-metry, esophageal manometry, endoscopy-biopsy and clinical assessment. At inclusion, there were no significant differences between the two groups regarding sex, age, grade of endoscopic esophagitis, manometric and pH-metry findings. All Hp-positive patients had an antral predominant gastritis. Eradication of Hp was successful in all patients, and gastritis and esophagitis were healed in all patients. The mean lower esophageal sphincter pressure (LESP) increased significantly from 11.25 mmHg before to 11.71 mmHg after eradication (P<0.05). A significant decrease in reflux index was observed (mean RI 6.02% before versus 4.96% after eradication (P<0.05). However clinical symptoms of GER improved not significantly after 6 months follow up. Conclusively, in children and young adults with GER symptoms and GERD, the presence or absence of Hp has no impact on manometric and pH-metric findings. Eradication of Hp infection results in increase in LESP with a consequent decrease in esophageal acid exposure but not significant clinical improvement.